amobarbital has been researched along with Paranoia in 3 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PROUT, CT | 1 |
| Kutsenok, BM | 1 |
| Silver, D | 1 |
| Lehmann, HE | 1 |
| Kral, VA | 1 |
| Ban, TA | 1 |
3 other studies available for amobarbital and Paranoia
| Article | Year |
|---|---|
REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
Topics: Alcoholism; Amobarbital; Amphetamine; Amphetamines; Barbiturates; Dextroamphetamine; Hospitals, Psyc | 1964 |
[On the differential diagnosis of relapsing schizophrenia].
Topics: Adolescent; Adult; Amobarbital; Catatonia; Delirium; Depression; Diagnosis, Differential; Female; Ha | 1966 |
Experimental geriatrics. Selection and prediction of therapeutic responsiveness in geriatric patients.
Topics: Aged; Amobarbital; Analysis of Variance; Carbon Dioxide; Hospitalization; Humans; Methamphetamine; N | 1968 |